The cardiorenal effects of chronic phosphodiesterase-v inhibition in preclinical diastolic dysfunction (stage b heart failure).

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2023)

引用 0|浏览3
暂无评分
摘要
[NCT02058095].
更多
查看译文
关键词
Heart failure with preserved ejection fraction, PDE V inhibition, tadalafil, cGMP
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要